Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
TCRX holding history
TScan Therapeutics, Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRX overviewAll 13F holders of TCRXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −1,932,304−100.0% | Sold out | Holders |
| Q3 2025 | 1,932,304 | $3.52M | 3.5% | −154,835−7.4% | Reduced | Holders |
| Q2 2025 | 2,087,139 | $3.03M | 3.7% | 00.0% | Unchanged | Holders |
| Q1 2025 | 2,087,139 | $2.88M | 3.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 2,087,139 | $6.34M | 6.3% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,087,139 | $10.4M | 6.0% | 00.0% | Unchanged | Holders |
| Q2 2024 | 2,087,139 | $12.2M | 7.9% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,087,139 | $16.6M | 9.6% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,087,139 | $12.2M | 10.1% | – | No prior filing | Holders |